Showing 151-160 of 2105 results for "".
Congenital Myasthenic Syndrome Treatment
https://practicalneurology.com/diseases-diagnoses/neuromuscular/congenital-myasthenic-syndrome-treatment/31555/Heterogeneity makes diagnosis and treatment challenging.Tenecteplase and the Future of Thrombolytics: A Practical Update for the Evolving Stroke Era
https://practicalneurology.com/diseases-diagnoses/stroke/tenecteplase-and-the-future-of-thrombolytics/49156/Tenecteplase is a practical alternative to alteplase for intravenous thrombolysis in acute ischemic stroke, offering pharmacologic and workflow advantages.Neuro-Oncology Outlook: Advancements in Targeted Molecular Therapy for Low-Grade Gliomas—Challenging the Treatment Paradigm
https://practicalneurology.com/diseases-diagnoses/imaging-testing/neuro-oncology-outlookbradvancements-in-targeted-molecular-therapy-for-low-grade-gliomas-challenging-the-treatment-paradigm/32121/Treatment with the IDH inhibitor vorasidenib increased median progression-free survival and time to next intervention in individuals with grade 2 gliomas under surveillance after surgical resection.Case Report: Cyclophosphamide as Rescue Agent in Myasthenic Crisis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/case-report-cyclophosphamide-as-rescue-agent-in-myasthenic-crisis/30120/When patients are refractory to first-line treatments for myasthenic crisis, cyclophosphamide may have benefits and warrants further study.Updates in Ischemic Stroke Imaging: A Review
https://practicalneurology.com/diseases-diagnoses/imaging-testing/updates-in-ischemic-stroke-imaging-a-review/56377/Understanding the strengths and limitations of CT, CTA, CTP, and MRI is essential for optimizing triage, treatment decisions, and outcomes in acute ischemic stroke care.Bacterial Endocarditis and Cerebrovascular Disease
https://practicalneurology.com/diseases-diagnoses/stroke/bacterial-endocarditis-and-cerebrovascular-disease/30452/Since stroke is a frequent complication of infective endocarditis, physicians should be up-to-date on the latest developments in diagnosis and management.Are Anti-amyloid Therapies Still Worth Being Developed as Treatments for Alzheimer's Disease?
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/are-anti-amyloid-therapies-still-worth-being-developed-as-treatments-for-alzheimers-disease/30832/Despite limited pharmaceutical success thus far, amyloid peptides may yet prove useful in the treatment of Alzheimer's and delay disease progression.The Pen Test
https://practicalneurology.com/diseases-diagnoses/movement-disorders/the-pen-test/30773/A proposed test to measure fine finger control in Parkinson's is accessible and cost effective. Can it catch on?Neurologic Complications of Globally Prevalent Infectious Disorders: A Focus on Syphilis, Cysticercosis, and Tuberculosis
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/neurologic-complications-of-globally-prevalent-infectious-disorders-a-focus-on-syphilis-cysticercosis-and-tuberculosis/32153/In the presence of CNS infections, neurologists should have a high index of suspicion for syphilis, tuberculosis, or cysticercosis, especially in people from endemic areas and immunocompromised individuals.Management of Poststroke Epilepsy: An Update
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/management-of-poststroke-epilepsy-an-update/32188/Poststroke seizure management is a clinical and research priority to improve prognosis.